Alzheimer's & Dementia

Alzheimer’s disease is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills. Alzheimer’s is the most common cause of dementia among older adults. Dementia is the loss of cognitive functioning—thinking, remembering, and reasoning—and behavioral abilities to such an extent that it interferes with a person’s daily life and activities.

Alzheimer’s Disease | Definition, Causes, Diagnosis & Treatment

Alzheimer’s Disease (AD) is the most common form of dementia worldwide (60-70% of all dementia cases) and is a progressive neurodegenerative disorder.

What are Amyloid Plaques?

Antidepressants and Dementia: Is There a Link?

Alzheimer's Disease Treatments

Mixed Dementia Prevention and Treatment

AAM - Genetics of Alzheimer's

Differences Between Alzheimer's and Dementia

Alzheimer's and Veganism

Inflammation and Alzheimer's Disease

Dementia Prevention

Transcutaneous Electrical Nerve Stimulation for Dementia

Does Depression and Anxiety Increase the Risk of Dementia?

See more featured articles »

Alzheimer's Disease and Sleep Disruption

Bright Light Therapy and Dementia

Gender and Alzheimer’s Risk

Biomarkers for Alzheimer's Disease

Migraines and Dementia

Dementia with Lewy Bodies

Dementia Diagnosis

Does Type 2 Diabetes Increase the Risk of Alzheimer’s Disease?

Amyloid Cascade Hypothesis

Can Statins Protect Against Alzheimer’s Disease?

Parkinson's Compared to Dementia with Lewy Bodies (DLB)

AAM - The Search for a Cure to Alzheimer's

Childhood Dementia Signs and Symptoms

Alzheimer's Disease Diagnosis

Alzheimer's Disease Symptoms

Does Herpesvirus Cause Alzheimer's?

Alzheimer's Disease Causes

Dementia Symptoms

Alzheimer's Disease Prevention

Alzheimer’s Disease and Gingko Biloba

Is Alzheimer's Disease Transmissible?

Alzheimer’s tangles and plaques: what’s the difference?

Alzheimer’s Disease and Calcium Supplements

AAM - Air pollution and Alzheimer's

Pollution and Alzheimer's

What Causes Dementia?

Aromatherapy for Dementia

Dementia Treatment

Alzheimer's Disease Epidemiology

Antibody Research and Alzheimer’s Disease

Can Happiness Protect You from Dementia?

Childhood Dementia Causes

Do Antioxidants Benefit Patients with Alzheimer’s and Parkinson’s?

Mixed Dementia Symptoms and Diagnosis

Diet and Alzheimer's Disease

Does Type 2 Diabetes Increase the Risk of Alzheimer’s Disease?

Mythbusting: Misconceptions in Dementia

Types of Alzheimer's Disease

Alzheimer's Disease and the Microbiome

Coconut Oil and Dementia

Integrated PET/MR for Alzheimer’s Disease

Designing Dementia-Friendly Environments

Stem Cell Therapy for Alzheimer's

Dancing Through Dementia: How Movement Aids Memory and Mood

What is Mixed Dementia?

Alzheimer's Disease Questions

Omega-3 and Alzheimer’s Disease

Stress and Alzheimer's Disease

What is Dementia?

Latest Alzheimer's & Dementia News and Research

Hypertension may induce early gene expression changes in brain cells

Hypertension impairs blood vessels, neurons and white matter in the brain well before the condition causes a measurable rise in blood pressure, according to a new preclinical study from Weill Cornell Medicine investigators.

14 Nov 2025

New insights into glioblastoma survival linked to brain fluid dynamics

Glioblastoma-the most aggressive form of brain cancer-remains one of medicine's biggest challenges. Despite surgery, radiotherapy, and chemotherapy, most patients survive only about a year after diagnosis.

14 Nov 2025

Empowering early detection of dementia with a dual approach involving AI and patient input

Few primary care practices are designed for the timely detection of Alzheimer's disease and related dementias. The limited time that primary care clinicians are able to spend with patients, the need to focus on the health problems which brought the patient to the clinic, as well as the stigma of Alzheimer's disease and dementia are major reasons for lack of recognition of the condition.

13 Nov 2025

TRIMTECH Therapeutics appoints Dr Mike Hutton to Scientific Advisory Board

TRIMTECH Therapeutics, a biotech company creating novel, small molecule therapeutics that selectively degrade protein aggregates, to combat neurodegenerative diseases, today announced the appointment of Dr Mike Hutton to its Scientific Advisory Board (SAB).

From TRIMTECH Therapeutics 12 Nov 2025

Income and social disparities found to influence dementia risk factors

People with lower incomes and people from racial and ethnic historically underrepresented groups in clinical studies are more likely to have modifiable risk factors for dementia, factors that could be changed to lower their risk, according to a study published November 12, 2025, in Neurology, the medical journal of the American Academy of Neurology.

12 Nov 2025

New Mayo Clinic tool predicts Alzheimer’s risk years before symptoms begin

Mayo Clinic researchers have developed a new tool that can estimate a person's risk of developing memory and thinking problems associated with Alzheimer's disease years before symptoms appear.

12 Nov 2025

What the air you breathe may be doing to your brain

For years, the two patients had come to the Penn Memory Center at the University of Pennsylvania, where doctors and researchers follow people with cognitive impairment as they age, as well as a group with normal cognition.

12 Nov 2025

Stress-induced neuron loss shown to disrupt blood flow and neural communication

While the exact causes of neurodegenerative brain diseases like Alzheimer's and dementia are still largely unknown, researchers have been able to identify a key characteristic in affected brains: reduced blood flow.

11 Nov 2025

Everyday speech patterns reveal hidden markers of brain health

The way we speak in everyday conversation may hold important clues about brain health, according to new research from Baycrest, the University of Toronto and York University.

11 Nov 2025

Amyloid-clearing drug fails to change waste clearance function in the brains of Alzheimer's patients

A group from Osaka Metropolitan University in Japan, led by graduate student Tatsushi Oura and Dr. Hiroyuki Tatekawa, found that treatment using the drug lecanemab to remove amyloid plaques in the brain does not change the waste clearance function in the brains of Alzheimer's disease (AD) patients in the short term.

11 Nov 2025

Midlife blood test may reveal Alzheimer’s disease risk in advance

A simple blood test for platelet activity at middle age could one day help identify people at risk for Alzheimer's disease decades ahead of time, allowing for possible preventive therapy.

11 Nov 2025

Shared genetic roots connect neurological and psychiatric disorders

In a groundbreaking study, researchers from the Centre for Precision Psychiatry at the University of Oslo and Oslo University Hospital have discovered extensive genetic links between neurological disorders like migraine, stroke and epilepsy, and psychiatric illnesses such as schizophrenia and depression.

11 Nov 2025

Targeting RNA splicing errors protects against tau-induced neurodegeneration

Alzheimer's Disease (AD), the leading cause of dementia, affects nearly 40 million individuals globally, resulting in a gradual loss of memory and independence. Despite extensive research over the past decades, no treatments have been found that can halt or reverse the progression of this devastating disease.

11 Nov 2025

Scientists pinpoint a reason Alzheimer’s patients forget loved ones

One of the most devastating moments for family members of a patient with Alzheimer's is when their loved one forgets who they are. New University of Virginia School of Medicine research may explain why that happens and could lead to a way to prevent it.

10 Nov 2025